Bupropion toxicokinetic: A case report

Clinical Toxicology

Volumn 48, Issue 4, 2010, Pages 385-387

  Donnelly, Kieran ^a   Walkowiak, Hannah Beth ^b   Donnelly, Christopher ^c   Jenkinson, Emma ^d   Rizkalla, Jonha ^e   Langford, Nigel ^b,e  

^a UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^b CITY HOSPITAL   (United Kingdom)

^c TRINITY COLLEGE   (United Kingdom)

^d NATIONAL HEALTH SERVICE   (United Kingdom)

^e SANDWELL AND WEST BIRMINGHAM HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Bupropion; Overdose; Toxicokinetics

Indexed keywords

AMFEBUTAMONE; DIAZEPAM;

ADULT; ARTERIAL GAS; ARTICLE; ATAXIA; AUDITORY HALLUCINATION; BRUXISM; CASE REPORT; DISEASE DURATION; DRUG OVERDOSE; ELECTROCARDIOGRAPHY; GLUCOSE BLOOD LEVEL; HUMAN; MALE; SINGLE DRUG DOSE; SINUS RHYTHM; SLURRED SPEECH; TONIC CLONIC SEIZURE; TOXICOKINETICS; TREMOR; VISUAL HALLUCINATION;

ADULT; ANTIDEPRESSIVE AGENTS; BUPROPION; DELAYED-ACTION PREPARATIONS; HUMANS; MALE; OVERDOSE;

EID: 77952919845     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.3109/15563651003623289     Document Type: Article

References (10)

1. Gnuplot version 4.2.4. http://www.gnuplot.info/. Accessed 26 December 2009.
2. Toxbase 2003. http://www.toxbase.org/Poisons-Index-A-Z/B-Products/ Bupropion. Accessed 23 September 2009.
3. GlaxoSmithKline. Zyban (Bupropion Hydrochloride) Sustained-Release Tablets: Product Information. Welwyn: GlaxoSmithKline; 2001.
4. Morazin F, Lumbroso A, Harry P, Blaise M, Turcant A, Montravers P, Gauzit R. Cardiogenic shock and status epilepticus after massive bupropion overdose. Clin Toxicol 2007; 45:794-797.
5. Joint Formulary Committee. British National Formulary. 57th ed. London: British Medical Association and Royal Pharmaceutical Society of Great Britain; 2009.
6. White RS, Langford JR. Sustained release bupropion: overdose and treatment. Am J Emerg Med 2002; 20:388-389.
7. Aalund G, Rivera W, Velez L, Keyes D, Benitez F. A documented bupropion bezoar in the emergency department. J Toxicol Clin Toxicol 2003; 41:510.
8. Findlay JW, Van Wyck Fleet J, Smith PG, Butz RF, Hinton ML, Blum MR, Schroeder DH. Pharmacokinetics of bupropion, a novel antidepressant agent, following oral administration to healthy subjects. Eur J Clin Pharmacol 1981; 21:127-135.
9. Kirchheiner J, Klein C, Meineke L, Sasse J, Zanger UM, Murdter TE, Roots L, Brockmoller J. Bupropion and 4-OH-bupropion pharmacokinetics in relation to genetic polymorphisms in CYP2B6. Pharmacogenetics 2003; 13:619-626.
10. Parkinson A, Leonard N, Draper A, Ogilvie BW. On the mechanism of hepatocarcinogenesis of benzodiazepines: evidence that diazepam and oxazepam are CYP2B inducers in rats, and both CYP2B and CYP4A inducers in mice. Drug Metab Rev 2006; 38:235-259.